678 related articles for article (PubMed ID: 26442664)
1. PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
Singh D; Somani VK; Aggarwal S; Bhatnagar R
Mol Immunol; 2015 Dec; 68(2 Pt A):272-9. PubMed ID: 26442664
[TBL] [Abstract][Full Text] [Related]
2. Recombinant L7/L12 protein entrapping PLGA (poly lactide-co-glycolide) micro particles protect BALB/c mice against the virulent B. abortus 544 infection.
Singh D; Goel D; Bhatnagar R
Vaccine; 2015 Jun; 33(24):2786-92. PubMed ID: 25930114
[TBL] [Abstract][Full Text] [Related]
3. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
[TBL] [Abstract][Full Text] [Related]
4. Escheriosome-mediated delivery of recombinant ribosomal L7/L12 protein confers protection against murine brucellosis.
Mallick AI; Singha H; Khan S; Anwar T; Ansari MA; Khalid R; Chaudhuri P; Owais M
Vaccine; 2007 Nov; 25(46):7873-84. PubMed ID: 17931756
[TBL] [Abstract][Full Text] [Related]
5. Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.
Mallick AI; Singha H; Chaudhuri P; Nadeem A; Khan SA; Dar KA; Owais M
Vaccine; 2007 May; 25(18):3692-704. PubMed ID: 17296251
[TBL] [Abstract][Full Text] [Related]
6. Protective and therapeutic efficacy study of divalent fusion protein rL7/L12-Omp25 against B. abortus 544 in presence of IFNγ.
Paul S; Peddayelachagiri BV; Nagaraj S; Konduru B; Batra HV
Appl Microbiol Biotechnol; 2018 Oct; 102(20):8895-8907. PubMed ID: 30136204
[TBL] [Abstract][Full Text] [Related]
7. Live vaccine consisting of attenuated Salmonella secreting and delivering Brucella ribosomal protein L7/L12 induces humoral and cellular immune responses and protects mice against virulent Brucella abortus 544 challenge.
Senevirathne A; Hewawaduge C; Lee JH
Vet Res; 2020 Jan; 51(1):6. PubMed ID: 31973749
[TBL] [Abstract][Full Text] [Related]
8. A combined subunit vaccine comprising BP26, Omp25 and L7/L12 against brucellosis.
Gupta S; Singh D; Gupta M; Bhatnagar R
Pathog Dis; 2019 Nov; 77(8):. PubMed ID: 31971564
[TBL] [Abstract][Full Text] [Related]
9. Immunogencity of HSA-L7/L12 (Brucella abortus ribosomal protein) in an animal model.
Pakzad I; Rezaee A; Rasaee MJ; Tabbaraee B; Delpisheh A
Iran J Immunol; 2009 Mar; 6(1):12-21. PubMed ID: 19293473
[TBL] [Abstract][Full Text] [Related]
10. Protection of BALB/C mice against Brucella abortus 544 challenge by vaccination with combination of recombinant human serum albumin-l7/l12 (Brucella abortus ribosomal protein) and lipopolysaccharide.
Pakzad I; Rezaee A; Rasaee MJ; Hossieni AZ; Tabbaraee B; Kazemnejad A
Roum Arch Microbiol Immunol; 2010; 69(1):5-12. PubMed ID: 21053778
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with recombinant L7/L12-truncated Omp31 protein induces protection against Brucella infection in BALB/c mice.
Golshani M; Rafati S; Dashti A; Gholami E; Siadat SD; Oloomi M; Jafari A; Bouzari S
Mol Immunol; 2015 Jun; 65(2):287-92. PubMed ID: 25723468
[TBL] [Abstract][Full Text] [Related]
12. Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection.
Tabynov K; Sansyzbay A; Kydyrbayev Z; Yespembetov B; Ryskeldinova S; Zinina N; Assanzhanova N; Sultankulova K; Sandybayev N; Khairullin B; Kuznetsova I; Ferko B; Egorov A
Virol J; 2014 Apr; 11():69. PubMed ID: 24716528
[TBL] [Abstract][Full Text] [Related]
13. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
[TBL] [Abstract][Full Text] [Related]
14. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
[TBL] [Abstract][Full Text] [Related]
15. Prime-booster vaccination of cattle with an influenza viral vector Brucella abortus vaccine induces a long-term protective immune response against Brucella abortus infection.
Tabynov K; Yespembetov B; Ryskeldinova S; Zinina N; Kydyrbayev Z; Kozhamkulov Y; Inkarbekov D; Sansyzbay A
Vaccine; 2016 Jan; 34(4):438-444. PubMed ID: 26709638
[TBL] [Abstract][Full Text] [Related]
16. Substantial Protective Immunity Conferred by a Combination of
Arayan LT; Huy TXN; Reyes AWB; Hop HT; Son VH; Min W; Lee HJ; Kim S
J Microbiol Biotechnol; 2019 Feb; 29(2):330-338. PubMed ID: 30609879
[TBL] [Abstract][Full Text] [Related]
17. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model.
Paul S; Peddayelachagiri BV; Nagaraj S; Kingston JJ; Batra HV
Mol Immunol; 2018 Jul; 99():9-18. PubMed ID: 29649688
[TBL] [Abstract][Full Text] [Related]
18. Induction of partial protection in mice after oral administration of Lactococcus lactis producing Brucella abortus L7/L12 antigen.
Pontes DS; Dorella FA; Ribeiro LA; Miyoshi A; Le Loir Y; Gruss A; Oliveira SC; Langella P; Azevedo V
J Drug Target; 2003; 11(8-10):489-93. PubMed ID: 15203917
[TBL] [Abstract][Full Text] [Related]
19. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal administration of a novel chimeric immunogen (rOP) elicits IFN-γ and IL-12p70 protective immune response in BALB/c mice against virulent Brucella.
Tadepalli G; Konduru B; Murali HS; Batra HV
Immunol Lett; 2017 Dec; 192():79-87. PubMed ID: 29106986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
